dc.date.accessioned2016-12-01T21:32:13Z
dc.date.available2016-12-01T21:32:13Z
dc.date.created2016-12-01T21:32:13Z
dc.date.issued2014
dc.identifier1556-6811
dc.identifierhttp://hdl.handle.net/10533/135189
dc.identifier1110925
dc.identifierWOS:000345532300004
dc.identifier1556-679X
dc.languageeng
dc.publisherAMERICAN SOCIETY FOR MICROBIOLOGY
dc.relationhttps://doi.org/10.1128/CVI.00416-14
dc.relation10.1128/CVI.00416-14
dc.relationinfo:eu-repo/grantAgreement/Fondecyt/1110925
dc.relationinfo:eu-repo/semantics/dataset/hdl.handle.net/10533/93477
dc.relationinstname: Conicyt
dc.relationreponame: Repositorio Digital RI2.0
dc.relationinstname: Conicyt
dc.relationreponame: Repositorio Digital RI2.0
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleEffectiveness of the e2-classical swine fever virus recombinant vaccine produced and formulated within whey from genetically transformed goats
dc.typeArticulo


Este ítem pertenece a la siguiente institución